A method for measuring erythrocyte transketolase activity (ETKA) is described that is precise, economical of reagents and capable of high throughput with partial or full automation. The transketolase-dependent transformation of ribose-5-phosphate, yielding glyceraldehyde-3-phosphate, is linked via 'indicator enzymes' to glycerol production and NADH consumption, the latter being followed fluorimetrically. Conditions under which ETKA and 'TPP Effect' are derived have been examined and optimised. Values are comparable with those obtained by other methods but a relatively narrow adult reference range for ETKA is observed. Data are presented for optimal preparation and storage of samples.
In thiamine deficiency, in vitro erythrocyte transketolase (EC 2.2.1.1.) activity (ETKA) falls whereas 'TPP Effect' (the percentage increase in ETKA reaction velocity that results from incorporation of thiamine pyrophosphate) rises. Both measurements are useful to assess body thiamine status. I, 2 Although several methods for these measurements have been described, each has limitations. The method of Hoffman et al., 3 measuring sedoheptulose produced in the transketolase reaction, is time-consuming, employs strong acid and requires critical temperature control during colour development. Similar considerations apply to other colorimetric methods.": 5 Smeets et at.(, used 'indicator enzymes' (enzymes catalysing a secondary reaction that allows indirect measurement of a product in the primary reaction) with NADH to measure transketolase-catalysed production of glyceraldehyde-3-phosphate, monitoring NADH consumption with continuous recording spectrophotometry at 340 nm. Considerable difficulties with this method and those derived from ie· II stem from the high background absorbance of haemolysate haemoglobin. Waring et al." overcame some of the problems by using a dialysis membrane to separate haemolysate and indicator enzymes but their continuous-flow system is expensive to run.
The present method uses the same principle employed by Smeets Fluorimetry is used, however, in the manner devised by Beutler and Mitchell!" to monitor NADH consumption in reaction mixtures containing large amounts of haemoglobin.
Materials and methods
APPARATUS.
Fluorimetry: Perkin-Elmer model LS-2 fluorimeter, with autochanger and Datak printer; Perkin-Elmer Ltd., Beaconsfield,~K.
340 nm excitation and 465 Assay procedure HAEMOLYSATE PREPARATION 5-10 mL whole heparinised blood is transferred to an ammonium heparinate tube (beads omitted) and centrifuged at 1100Xg for 10 min at 4°C. Plasma and buffy-coat layers are removed by suction, and packed erythrocytes resuspended in two volumes of cold (4°C) 154 mM sodium chloride. After centrifugation for 5 min, supernatant and residual leucocytes are again removed, and a second wash given. After removal of supernatant, de-ionised distilled water is added in volume equal to that of the packed erythrocytes, and the sample mixed thoroughly to promote osmotic lysis.
Further lysis is achieved by freeze-thawing (x 2) in liquid nitrogen. Complete freezing, to uniform temperature, is attained by immersion for 2 min. Rapid thawing is effected under a hot tap, with constant agitation to avoid localised excessive temperature in the haemolysate as it melts. After the second freeze, aliquots for storage are kept at -70°C whereas samples for immediate assay are thawed directly. HAEMOGLOBIN DETERMINATION 50 ul, of haemolysate is mixed with 10 mL of Drabkin's solution and allowed to stand for 20 min. Haemoglobin concentration is derived from absorbance values at 540 nm and calibration curves prepared from haemoglobin standards. For each sample, the volume (x ilL) of haemolysate containing 20 mg haemoglobin is then calculated.
TRANS KETO LASE ASSAY
For each assay, three 5 mL conical plastic centrifuge tubes are placed line abreast in the water bath at 37 c C. These are here referred to as a 'mix' tube ('M'), and two reaction tubes ('A' and 'B'). 40 ul, of Tris-HCl buffer is placed in each tube'A', and 40 ul, of TPP solution in each tube 'B'. Each tube 'M' is then filled, as follows: The first 'M' tube is for a reagent blank mixture, with 160 ul, of Tris solution substituting for haemolysate. Fifteen minutes after preparing each 'M' tube, 1 mL aliquots are removed and placed in respective tubes 'A' and 'B' at 20 s intervals. Mixing at this point is taken to initiate fully the reaction sequence at the required substrate concentrations, with and without added thiamine. 'M' tubes are now discarded.
The sampling sequence begins 30 min afterwards, with substrate having thus been exposed to haemolysate transketolase for a total of 45 min. 100 ilL aliquots are mixed with 4·9 mL of phosphate buffer, the requisite plastic containers being loaded on to the autosampler tray. Averaged readings on the diluted samples are printed out, each assay involving seven pairs of readings taken at 10 min intervals.
Standardisation, using 8 and 16 IlM concentrations of NADH, is performed immediately before and after each complete batch. Predetermined 'Cavro' programmes are used throughout the assay procedure, and in this instance give the required (1:25 and 1:12,5) dilutions of intermediate NADH standard in phosphate buffer.
Aspects studied in development of the assay system QUENCHING OF FLUORESCENCE BY HAEMOGLOBIN The fluorescence of NADH at final concentrations of 4, 8, 12, 16, 20 and 24 nmollL in phosphate buffer was studied in the presence of haemoglobin ('Diagen') at concentrations equivalent to 0, 7·5, 15, 22·5 and 30 mg of haemolysate haemoglobin in the reaction mixture.
TEMPERATURE OF PHOSPHATE BUFFER
A calibrated thermocouple probe was attached to tubing immediately leading to the fluorimeter flowcell, readings from a digital display unit being used to study the effect of altered phosphate buffer temperature (range 18-32 c C) on NADH fluorescence.
NUMBER OF FREEZE/THAWS
The effect of increasing numbers of freeze/thaw cycles, from 0 to 5, was studied in eight aliquoted samples, four with normal 'TPP Effects' (defined as~15'5% after two freeze/ thaws), and four with abnormal 'TPP Effects' (> 15,5%). Each study comprised six duplicate assays performed in one batch.
TIME-COURSE OF ETKA VELOCITIES AND 'TPP EFFECT'
These aspects were studied, from the moment of adding TPP to a point up to 140 min afterwards, in eight samples with abnormal 'TPP Effects', and four with normal 'TPP Effects'.
QUANTITY OF HAEMOLYSATE
In two samples, derived ETKA values were studied in relation to different quantities (0, 5, 10, 15, 20 and 30 mg) of haemolysate in the 'mix' tube. NADH concentrations were adjusted to maintain mid-range fluorimeter readings, but other reaction concentrations were kept constant. Each study was performed in a single batch, with six duplicate assays. This was studied in 20 of the above subjects, samples taken between 8 and 10 pm being stored overnight as whole blood at 4°C before being compared with samples taken 12 h later.
PRECISION STUDIES
Within-batch and between-batch duplicates were run covering several ranges of activity defined in relation to the midpoint and lower limit of the reference range of ETKA.
To check the intrinsic value of 'TPP Effect' derived by our method, the effect of adding TPP to four heparinised whole blood samples was studied. 30 mL samples were divided into six 5 ml aliquots, one of which was processed directly to the haemolysate stage. 50 ul, of 10 mx TPP solution was added to 4 aliquots, each of which was incubated at 37°C, mixed regularly and processed (with four saline washes) at 1, 2, 3'12 or 5 h. A further control aliquot was similarly incubated (without TPP) and processed at 5 h. Each single-batch study thus comprised duplicated assays on six samples.
STORAGE STUDIES
Storage properties of haemolysate at -70°C for 2 weeks, 1 month, and 2 months were studied in aliquots of 10 samples with abnormal 'TPP Effects' and four samples with normal 'TPP Effects'. Storage of haemolysate and whole 
Results
On the model LS-2 fluorimeter a haemoglobin content of 20 mg in the reaction mixture was associated with a 'quench factor' (0) for NADH of 0·938, where a quench factor of 1·000 indicates zero quenching. Ouenching does not affect the linearity of calibration curves provided the haemoglobin concentration remains constant (Fig. 1) .
Readings from NADH fluorescence fall by 2% per°C as temperature rises through the range studied. However, a constant-temperature diluent reservoir maintains temperature of diluted samples to within ±0·25°C, and hence of fluorimeter readings to within ±0·5% over the assay period, provided care is taken also to avoid excessive changes in room temperature.
Because reduction in fluorescence of reagent blank samples is negligible «0·2%), calculations are simple and may proceed as follows (Fig. 2.) . . . . 300
.. ..
-. . Smeets et al. stated (without supportive data) that full activity was released with one freeze/ thaw cycle, and that activity fell with further cycles. Present data do not support this commonly-held view. In each of the eight aliquoted samples studied the mean of activity liberated after three, four and five freeze/thaws could be taken as maximal activity, since variation was ± 1% with no clear trend. An average 99·3% of maximal activity was liberated from two freeze/thaws, but only 96·6% (range 93·7-99·5%) from one freeze/thaw. In abnormal cases no change in 'TPP Effect' was discernible after more than two freeze/thaws. An interesting finding concerns the apparently biphasic nature of the transketolase reaction ( Fig. 3) . Both stimulated and unstimulated ET~A appear to fall rapidly during the first 30 min of full incubation, and this fall is most marked in the unstimulated ETKA of abnormal samples. However, more than 200 consecutive duplicate samples have now been tested, with an actrvity range of 250-1150 mU/g Hb, and progress curves from all of these indicate that between 30 and 90 min there is acceptable linearity for both stimulated and unstimulated ET.KA.
When the quantity of haemolysate in the reaction mixture is varied, values for ETKA remain constant as long as appropriate allowance is made for different haemoglobin quench factors.
Other authors imply that increasing TPP concentrations above a certain point yield no further change in 'TPP Effect'. However, present findings indicate that for any given set of reaction conditions there may be an optimal TPP concentration, which if exceeded can lead to some degree of 'substrate' inhibition. Some commonly exhibited affinity patterns applying to our assay system are shown in Fig. 4 .
Centrifugation of haemolysate to remove red cell stroma led to no detectable' changes in derived values for haemoglobin level, ETKA or 'TPP Effect'. No changes in ETKA or 'TPP Effect' could be attributed to higher concentrations of ribose-5-phosphate, or to changes in concentration of GDH-TIM. Diurnal changes in ETKA values and 'TPP Effects' were inside Fluorimetric measurement of ETKA 185 TPP while kept intact as whole blood at 37°C. After 5 h of such incubation it appeared in all cases that 'unstimulated' ETKA was asymptotically approaching the stimulated activity of control erythrocytes: 'TPP Effects' were, correspondingly, approaching zero. In the present ETKA method the obvious advantage of proceeding directly to cell disruption for estimation of 'TPP Effects' is thus one of speed without apparent loss of accuracy. An overall adult reference range for ETKA of 570-830 mU/g Hb (mean=698·4, SD=65·3) was derived from 31 samples with 'TPP Effects' 15·5% (mean 10·3%, range 2·7-15·3%). Seven out of 11 subjects with 'TPP Effects' greater than 15·5% (mean 20·3%, range 15·6-28·6%) had ETKA values below this reference range, the mean of these 'abnormal' ETKA values being 552·2, SD 109·1. A bimodal distribution of ETKA values was thus clearly demonstrated ( Fig. 5, P<0·OOO5 , Student's single-tailed r-test applied to differences in means of small samples).
In 'normal' results, as defined above, no discernible trend was attributable to age or sex. At least one 'abnormal' result was obtained from each of the six age/sex sub-samples studied. Subjects with abnormal results included three with admitted regular alcohol intake (one with raised liver enzyme levels), a heroin addict, a patient with a history of small intestinal resection, two 'weight-watchers', and two isolated and severely handicapped elderly subjects (one with Parkinson's disease, the other with a right-sided hemiplegia).
Convergence is observed (Fig. 6 ) between in vitro TPP Effects' as derived by our method, and as could be derived through comparison with controls of erythrocytes stimulated with 
Discussion
was demonstrated in all 10 abnormal samples studied. The present ETKA method strikes a balance between the need for minimum batchprocessing time and improved steady-state kinetics, reproducibility and potential for automation. A prime concern was to minimise factors that might distort the TPP Effect'. The usefulness of ETKA measurements was Table. For all ranges of activity there was little difference in the SEM's for 'TPP Effect' between 10 and 15·5% and those for abnormal values. The lower part of the Table shows mean betweenbatch CV's and SEM's as derived from the duplicate studies of samples stored at -70°C for up to two months. In none of 10 abnormal and four normal samples was any consistent trend detectable in respect of ETKA or 'TPP Effect'.
Previous authors have reported that ETKA of haemolysates remained stable for a few hours at room temperature, and for several days at 4°C. 11 Present findings indicate that while unstimulated ETKA values for haemoly sates at 4°C remain relatively stable for 1-2 days, thereafter values become increasingly erratic. Moreover, in abnormal samples there is a general and progressive decline in 'TPP Effect' averaging (in absolute terms) 2·0% at 24 hand 4·3% at four days. 'TPP Effect' has been observed to deteriorate swiftly (sometimes more than 1% per hour) in thawed haemolysates left at room temperature. Figure 7 illustrates that both ETKA and 'TPP Effect' are stable for 24 h when samples are stored as whole blood iit 4°C. Comparison between values for ETKA at days 0 and 4, and those for TPP Effect' at 0 and 24 h, were compatible with within-batch coefficients of variation, with no obvious trend. However, between 24 and 48 h a decline in TPP Effect' established both experimentally and clinically over 25 years ago. i, 2 The two components of this functional assay have since served as a mainstay of research into the epidemiology of altered body thiamine status. Nevertheless, there remain substantial areas of everyday clinical practice where altered thiamine status could be vitally important but which have remained under-investigated from this point of view: notably metabolic (lactic) acidosis, 12 hepatorenal syndrome, septic shock and endocarditis. 13. 14. 15 Factors delaying progress include the low throughput and poor precision of existing ETKA methods, inviting dismissal of the ETKA functional assay principle itself as indirect, or of questionable suitability. 16. 17 Yet 'direct' measurements of thiamine and its esters in whole blood'": lK are just as slow, and perhaps more difficult.
To suggest'" that the functional assay principle may now be discarded in favour of such measurements is certainly premature. Reference ranges for whole blood thiamine levels have yet to be defined in the context of marked day-to-day, and even hour-to-hour variations. 19 Moreover, the observation that thiamine and its esters appear to be released in high concentrations from damaged hepatocytes in active liver disease ,!" while indicating a possible factor in the pathogenesis of hepatorenal syndrome.r" must cast doubt on the overall suitability of these measurements. Such limitations would also apply to microbiological assays for blood thiamine levels, which are in any case precluded by antibacterial treatment.
An uncritical approach to the ETKA principle may also cause problems. One investigation of thiamine status in patients with cirrhosis, using 20 laboratory personnel as controls, cited 40% as the upper limit of normal for 'TPP Effect'.21 This threshold is actually higher than the average maximum 'TPP Effect' of 34% reported by Brin during six weeks' experimental thiamine deficiency, and the mean value of 34·6% found in 21 Japanese cases of overt cardiovascular beri-beri. 19 Whatever allowance is made for distorting factors in the particular method used in the first study, the threshold of 40% appears unacceptably high, perhaps stemming from failure to appreciate that thiamine deficiency may occur in apparently asymptomatic and well individuals. I. 2. 19. 22 Application of a generally accepted threshold, such as 15% or even 20%, would have increased the proportion of indivi-duals adjudged deficient from 30% to somewhere between 60% and 80%.
Brin observed a progressive rise in values for 'TPP Effects', reaching between 15% and 20% after 2-3 weeks' thiamine deficient diet fed to previously healthy, vitamin-repleted volunteers, at which time deficiency symptoms first appeared in some cases. The observed maximum figure of 34% occurred at four weeks, but mean values for 'TPP Effect' subsequently fell again, to around 20% at 6 weeks. 'TPP Effect' can disappear completely in chronic deficiency, particularly associated with alcoholic liver disease.f as well as during dietary or therapeutic replacement: in these situations a welldefined reference range for ETKA is particularly useful.
Our data appear to indicate that, if a method that does not distort 'TPP Effect' is used to study the general population, a cut-off point for normality in 'TPP Effect' corresponding (in whole-number terms) to Brin's figure of 15% may be used to delineate a useful adult reference range for ETKA values. Further clarification of this issue is expected to follow from dietary assessments and biochemical follow-up studies that have been undertaken.
Possible reasons for the observed biphasic nature of the ETKA reaction curve (i.e. high initial reaction velocity as distinct from 'lag' phase) include initial changes in stoichiometry, or the presence of a labile transketolase fraction which either denatures or alters conformation to yield an enzyme-substrate complex of lower turnover number.
It is noteworthy that limits of the reference range for ETKA are somewhat lower and narrower than those of most other assay systems. The present kinetic findings could account for this, and partly explain the relatively poor reproducibility of other methods such as that of Smeets et al. 6 Unfortunately, this latter method's relatively short incubation and reaction times, and the distorting effects of haemolysate haemoglobin, make it unsuitable as a means of corroborating the present data.
A recent method paper, based on sedoheptulose determination and incubation periods of up to 90 min, appears to corroborate our kinetic findings." These authors advocate pre-heating haemolysate at 55°C for 5 min, since this appears to inactivate transaldolase and marginally improve the stoichiometry of the transketolase reaction. However, such treatment seems unjustified since it was reported also to distort the 'TPP Effect', otherwise accepted as the more sensitive and useful single aspect of the transketolase assay. I. 2. 19 It has recently been reported that various isoenzyme patterns of erythrocyte transketolase are discernible, one of which is more common in the Wernicke-Korsakoff syndrorne.P The precision and large within-batch capacity of the present method could help to clarify the meaning, in functional terms, of such molecular patterns.
Stability data were gathered in response to information kindly supplied by Puxty et al., 11 principally concerning serious deterioration of ETKA and 'TPP Effects' during two weeks' storage of haemolysate at -20°C. Leunis et al. have recently reported similar losses of activity.r" With -70°C refrigeration available, it seemed sensible to see if this temperature gave better results. Recent attention has been drawn to marked upward temperature fluctuation in refrigerators rated at -20°C when there is frequent opening for deposition and removal of samples.P Of concern also is the possibility that detergent, used by the above groups (and others) for cell lysis, accelerates deterioration. By contrast Smeets et al., 6 using a freeze/thaw technique and storage at -20°C, stated that haernolysates were stable for four weeks. However, until all the component aspects of haemolysate preparation and long term storage have been adequately studied, our data must suggest that a combination of freeze/thaw technique and -70°C refrigeration is advisable.
Present data on storage of whole blood at 4°C appears to represent an improvement over storage, both of washed cells at 4°C and of whole blood at room temperature. I I Useful information can thus be gained on patients arriving in hospital at night or over the weekend, without excessive demands on laboratory staffs time or the necessity to withhold treatment.
In Japan, the recent 'rediscovery' of thiamine deficiency as cause of beri-beri 15 has led to creation of national reference laboratories, principally using the transketolase assay. 19 There are indications that similar needs will come to be felt elsewhere.
